News

ahajournals.org2d
Relation Between Lesion Characteristics and Risk With Percutaneous Intervention in the Stent and Glycoprotein IIb/IIIa Era
The ACC/AHA lesion risk classification schema has been criticized because of its subjectivity and because it emanates from an era when stents and glycoprotein IIb/IIIa inhibitors in particular were ...
ahajournals.org4d
Effects of Abciximab, Ticlopidine, and Combined Abciximab/Ticlopidine Therapy on Platelet and Leukocyte Function in Patients Undergoing Coronary Angioplasty
The effect of each therapy on platelet-leukocyte interactions was also investigated. Conclusions—Combined therapy with abciximab and ticlopidine has a prolonged inhibitory effect on mural thrombosis ...
ascopubs.org4d
Randomized Phase III Study of Surgery Alone or Surgery Plus Preoperative Cisplatin and Gemcitabine in Stages IB to IIIA Non–Small-Cell Lung Cancer
for patients who were candidates for radical resection with clinical stage IB, II, and IIIA NSCLC. Chemotherapy- and radiotherapy-naive patients were required to have stage I (except for T1N0), II, or ...
jnis.bmj5d
Cangrelor versus GPIIb/IIIa inhibitors as adjunctive therapy in endovascular treatment of large vessel occlusion stroke
While glycoprotein (GP) IIb/IIIa inhibitors have been widely studied in ischemic stroke, cangrelor remains less explored. Objective To evaluate the safety and efficacy of cangrelor compared with GPIIb ...